Utilization and Safety of Ipilimumab Plus Nivolumab in a Real-World Cohort of Metastatic Renal Cell Carcinoma Patients

Myuran Thana; Naveen S. Basappa; Sunita Ghosh; Christian K. Kollmannsberger; Daniel Y.C. Heng; Aaron R. Hansen; Jeffery Graham; Denis Soulières; Martin Neil Reaume; Aly Khan A. Lalani; Vincent Castonguay; Georg A. Bjarnason; François Patenaude; Rodney H. Breau; Frédéric Pouliot; Anil Kapoor; Lori A. Wood

doi:10.1016/j.clgc.2021.12.003

Utilization and Safety of Ipilimumab Plus Nivolumab in a Real-World Cohort of Metastatic Renal Cell Carcinoma Patients

Myuran Thana, Naveen S. Basappa, Sunita Ghosh, Christian K. Kollmannsberger, Daniel Y.C. Heng, Aaron R. Hansen, Jeffery Graham, Denis Soulières, Martin Neil Reaume, Aly Khan A. Lalani, Vincent Castonguay, Georg A. Bjarnason, François Patenaude, Rodney H. Breau, Frédéric Pouliot, Anil Kapoor, Lori A. Wood

科研成果: 期刊稿件 › 文章 › 同行评审

3 引用（Scopus）

源语言	英语
页（从-至）	210-218
页数	9
期刊	Clinical Genitourinary Cancer
卷	20
期	3
DOI	https://doi.org/10.1016/j.clgc.2021.12.003
出版状态	已出版 - 6月 2022
已对外发布	是

!!!ASJC Scopus Subject Areas

泌尿学
肿瘤学

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1016/j.clgc.2021.12.003

其它文件与链接

引用此

Thana, M., Basappa, N. S., Ghosh, S., Kollmannsberger, C. K., Heng, D. Y. C., Hansen, A. R., Graham, J., Soulières, D., Reaume, M. N., Lalani, A. K. A., Castonguay, V., Bjarnason, G. A., Patenaude, F., Breau, R. H., Pouliot, F., Kapoor, A., & Wood, L. A. (2022). Utilization and Safety of Ipilimumab Plus Nivolumab in a Real-World Cohort of Metastatic Renal Cell Carcinoma Patients. Clinical Genitourinary Cancer, 20(3), 210-218. https://doi.org/10.1016/j.clgc.2021.12.003

Thana, M, Basappa, NS, Ghosh, S, Kollmannsberger, CK, Heng, DYC, Hansen, AR, Graham, J, Soulières, D, Reaume, MN, Lalani, AKA, Castonguay, V, Bjarnason, GA, Patenaude, F, Breau, RH, Pouliot, F, Kapoor, A & Wood, LA 2022, 'Utilization and Safety of Ipilimumab Plus Nivolumab in a Real-World Cohort of Metastatic Renal Cell Carcinoma Patients', Clinical Genitourinary Cancer, 卷 20, 号码 3, 页码 210-218. https://doi.org/10.1016/j.clgc.2021.12.003

@article{54fae79b6e184d77ac4ca96bacd836de,

title = "Utilization and Safety of Ipilimumab Plus Nivolumab in a Real-World Cohort of Metastatic Renal Cell Carcinoma Patients",

keywords = "Immune checkpoint inhibitors, Immune-related adverse effects, Immuno-oncology, Immunotherapy, Retrospective",

author = "Myuran Thana and Basappa, {Naveen S.} and Sunita Ghosh and Kollmannsberger, {Christian K.} and Heng, {Daniel Y.C.} and Hansen, {Aaron R.} and Jeffery Graham and Denis Souli{\`e}res and Reaume, {Martin Neil} and Lalani, {Aly Khan A.} and Vincent Castonguay and Bjarnason, {Georg A.} and Fran{\c c}ois Patenaude and Breau, {Rodney H.} and Fr{\'e}d{\'e}ric Pouliot and Anil Kapoor and Wood, {Lori A.}",

note = "Publisher Copyright: {\textcopyright} 2021",

year = "2022",

month = jun,

doi = "10.1016/j.clgc.2021.12.003",

language = "English",

volume = "20",

pages = "210--218",

journal = "Clinical Genitourinary Cancer",

issn = "1558-7673",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - Utilization and Safety of Ipilimumab Plus Nivolumab in a Real-World Cohort of Metastatic Renal Cell Carcinoma Patients

AU - Thana, Myuran

AU - Basappa, Naveen S.

AU - Ghosh, Sunita

AU - Kollmannsberger, Christian K.

AU - Heng, Daniel Y.C.

AU - Hansen, Aaron R.

AU - Graham, Jeffery

AU - Soulières, Denis

AU - Reaume, Martin Neil

AU - Lalani, Aly Khan A.

AU - Castonguay, Vincent

AU - Bjarnason, Georg A.

AU - Patenaude, François

AU - Breau, Rodney H.

AU - Pouliot, Frédéric

AU - Kapoor, Anil

AU - Wood, Lori A.

PY - 2022/6

Y1 - 2022/6

KW - Immune checkpoint inhibitors

KW - Immune-related adverse effects

KW - Immuno-oncology

KW - Immunotherapy

KW - Retrospective

UR - http://www.scopus.com/inward/record.url?scp=85123871032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85123871032&partnerID=8YFLogxK

U2 - 10.1016/j.clgc.2021.12.003

DO - 10.1016/j.clgc.2021.12.003

M3 - Article

AN - SCOPUS:85123871032

SN - 1558-7673

VL - 20

SP - 210

EP - 218

JO - Clinical Genitourinary Cancer

JF - Clinical Genitourinary Cancer

IS - 3

ER -

Utilization and Safety of Ipilimumab Plus Nivolumab in a Real-World Cohort of Metastatic Renal Cell Carcinoma Patients

!!!ASJC Scopus Subject Areas

联合国可持续发展目标

访问文件

其它文件与链接

指纹

引用此